US Patent Issued to ROSETTA SIGNALING LABORATORIES on Nov. 18 for "Combinations of biomarkers for methods for detecting trisomy 21" (Kansas Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,355, issued on Nov. 18, was assigned to ROSETTA SIGNALING LABORATORIES LLC.

"Combinations of biomarkers for methods for detecting trisomy 21" was invented by Carl Philip Weiner (Mission Hills, Kan.) and Yafeng Dong (Overland Park, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for detecting a Group of Biomarkers is provided herein. The translation profile of the Group of Biomarkers can be used for determining whether a subject, such as a fetus, has Down syndrome The methods include detecting one or more specific groups of biomarkers in a biological sample, and determining whether the expression of the biomarkers is altered when compared...